These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35332698)

  • 21. Investigation of a recently detected 11-nor-9-carboxy-Δ(9)-tetrahydrocannabinol isomer: Studies on the degradation of 11-nor-9-carboxy-Δ(9)-tetrahydrocannabinol glucuronide.
    Hanisch S; Paulke A; Toennes SW
    J Pharm Biomed Anal; 2016 Sep; 129():294-298. PubMed ID: 27448313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetic modeling of plasma Δ9-tetrahydrocannabinol and an active and inactive metabolite following controlled smoked cannabis administration.
    Sempio C; Huestis MA; Mikulich-Gilbertson SK; Klawitter J; Christians U; Henthorn TK
    Br J Clin Pharmacol; 2020 Mar; 86(3):611-619. PubMed ID: 31747464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying new cannabis use with urine creatinine-normalized THCCOOH concentrations and time intervals between specimen collections.
    Smith ML; Barnes AJ; Huestis MA
    J Anal Toxicol; 2009 May; 33(4):185-9. PubMed ID: 19470219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An investigation of the stability of free and glucuronidated 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in authentic urine samples.
    Skopp G; Pötsch L
    J Anal Toxicol; 2004; 28(1):35-40. PubMed ID: 14987422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.
    Manno JE; Manno BR; Kemp PM; Alford DD; Abukhalaf IK; McWilliams ME; Hagaman FN; Fitzgerald MJ
    J Anal Toxicol; 2001 Oct; 25(7):538-49. PubMed ID: 11599597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.
    Sholler DJ; Spindle TR; Cone EJ; Goffi E; Kuntz D; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R
    J Anal Toxicol; 2022 May; 46(5):494-503. PubMed ID: 34089060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary excretion of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users.
    Smith-Kielland A; Skuterud B; Mørland J
    J Anal Toxicol; 1999 Sep; 23(5):323-32. PubMed ID: 10488918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol: a delta9-THCCOOH to creatinine ratio study.
    Fraser AD; Worth D
    J Anal Toxicol; 1999 Oct; 23(6):531-4. PubMed ID: 10517562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of Cannabis Brownies: A Controlled Examination of Δ9-Tetrahydrocannabinol and Metabolites in Blood and Oral Fluid of Healthy Adult Males and Females.
    Spindle TR; Cone EJ; Herrmann ES; Mitchell JM; Flegel R; LoDico C; Bigelow GE; Vandrey R
    J Anal Toxicol; 2020 Oct; 44(7):661-671. PubMed ID: 32591782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid quantification of free and glucuronidated THCCOOH in urine using coated well plates and LC-MS/MS analysis.
    Hädener M; Weinmann W; van Staveren DR; König S
    Bioanalysis; 2017 Mar; 9(5):485-496. PubMed ID: 28176545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid elimination of Carboxy-THC in a cohort of chronic cannabis users.
    Lewis J; Molnar A; Allsop D; Copeland J; Fu S
    Int J Legal Med; 2016 Jan; 130(1):147-52. PubMed ID: 26233612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing cannabis consumption frequency: Is the combined use of free and glucuronidated THCCOOH blood levels of diagnostic utility?
    Hädener M; Martin Fabritius M; König S; Giroud C; Weinmann W
    Drug Test Anal; 2017 Jul; 9(7):1043-1051. PubMed ID: 27732768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The urinary disposition of intravenously administered 11-nor-9-carboxy-delta-9-tetrahydrocannabinol in humans.
    Dietz L; Glaz-Sandberg A; Nguyen H; Skopp G; Mikus G; Aderjan R
    Ther Drug Monit; 2007 Jun; 29(3):368-72. PubMed ID: 17529896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabis.
    Scheidweiler KB; Schwope DM; Karschner EL; Desrosiers NA; Gorelick DA; Huestis MA
    Clin Chem; 2013 Jul; 59(7):1108-17. PubMed ID: 23519966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous GC-EI-MS determination of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol in human urine following tandem enzyme-alkaline hydrolysis.
    Abraham TT; Lowe RH; Pirnay SO; Darwin WD; Huestis MA
    J Anal Toxicol; 2007 Oct; 31(8):477-85. PubMed ID: 17988462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis.
    Desrosiers NA; Himes SK; Scheidweiler KB; Concheiro-Guisan M; Gorelick DA; Huestis MA
    Clin Chem; 2014 Apr; 60(4):631-43. PubMed ID: 24563491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a rapid column-switching LC-MS/MS method for the quantification of THCCOOH and THCCOOH-glucuronide in whole blood for assessing cannabis consumption frequency.
    Hädener M; Weinmann W; Schürch S; König S
    Anal Bioanal Chem; 2016 Mar; 408(7):1953-62. PubMed ID: 26781107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
    Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
    Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.
    Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ
    J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
    Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA
    Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.